Anika Therapeutics, Inc. (ANIK)
ANIK Price and Sentiment
ANIK Latest news
Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting
2021-09-30 09:00Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist arthritis and an alternative to wrist fusion Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist arthritis and an alternative to wrist fusion
Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation
2021-09-14 09:00510(k) clearance expands the capability of Tactoset for augmenting suture anchor fixation 510(k) clearance expands the capability of Tactoset for augmenting suture anchor fixation
Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
2021-09-07 10:00BEDFORD, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 15, 2021 at 2:00 p.m. ET.
Anika to Debut Joint Preservation Portfolio at the 2021 AAOS Annual Meeting
2021-09-01 10:05Anika, now combined with Arthrosurface and Parcus Medical, meets the evolving unmet needs of surgeons in the global joint preservation market Anika, now combined with Arthrosurface and Parcus Medical, meets the evolving unmet needs of surgeons in the global joint preservation market
Anika Therapeutics' (ANIK) CEO Cheryl Blanchard on Q2 2021 Results - Earnings Call Transcript
2021-08-07 03:17Anika Therapeutics' (ANIK) CEO Cheryl Blanchard on Q2 2021 Results - Earnings Call Transcript
Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
2021-07-19 10:00BEDFORD, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its second quarter 2021 financial results after the close of the market on Thursday, August 5, 2021 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.
Anika to Host its 2021 Virtual Investor Day on June 3, 2021
2021-05-13 11:00BEDFORD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to host its 2021 Virtual Investor Day on Thursday, June 3, 2021 beginning at 9:00am EDT.
Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q1 2021 Results - Earnings Call Transcript
2021-05-09 16:30Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q1 2021 Results - Earnings Call Transcript
Anika Therapeutics (ANIK) Surpasses Q1 Earnings and Revenue Estimates
2021-05-06 21:02Anika (ANIK) delivered earnings and revenue surprises of 225.00% and 5.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Anika to Participate in Upcoming Virtual Investor Conferences
2021-05-04 10:30BEDFORD, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following three virtual investor conferences in May: